.... this post / comment didn't age well from 1 July 2022 ....
"The above is a realistic list of things that I believe can occur over the next 4-5 months"
15 months later and ....
https://hotcopper.com.au/threads/lo...eading-up-to-agm.6822445/reply?quote=62316349
Read out on Dep Docetaxel and part of Dep Cabazitaxel
NO
Dep Gemcitabine entering the clinic
NO
Further expansion of indications in clinic for AZD0466
NO - AZD0466 in fact now dead in the water
TGA approval for Viraleze in Australia
NO
New partnership agreement with radiotherapeutics
NO - research agreement with no $ paid to Starpharma isn't what I would call a partnership
Merck beginning first in human clinical trials with ADC's
NO
FDA NDA update
NO - nothing lodged with FDA yet coming up to 5 years
Monetising undisclosed former blockbuster drug of Astrazeneca with Starpharma's improved version
NO
Sacking of Mundipharma and finding a real partner
YES - no new distribution deal yet though
Licensing our internal in house Dep drugs
NO
The above is a realistic list of things that I believe can occur over the next 4-5 months
Of course there are many other possibilities.......... NO - nothing noteworthy
Look forward to a very productive quarter
- Forums
- ASX - By Stock
- SPL
- Looking forward to the following leading up to AGM
Looking forward to the following leading up to AGM, page-14
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.004(4.40%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
9.2¢ | 9.6¢ | 9.2¢ | $81.30K | 864.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 1285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 0.095 |
2 | 110498 | 0.094 |
1 | 26688 | 0.092 |
1 | 49413 | 0.091 |
4 | 122750 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 1285 | 1 |
0.100 | 112106 | 4 |
0.105 | 66531 | 3 |
0.110 | 16500 | 2 |
0.115 | 109827 | 3 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |